Medical technology company Biotronik has introduced its portable monitoring device, CardioMessenger Smart in the US.
The device, which is the same size as a modern smartphone enables physicians to stay remotely connected with their pacemaker, implantable cardioverter defibrillator (ICD), and insertable cardiac monitor (ICM) patients subsequently improving the care management from any location.
It transmits vital information from the patient’s implanted cardiac device to their physician in an automated way by Biotronik’s home monitoring device which includes daily, automatic reports and fully customisable alerts that can be tailored to the physician’s specifications.
In the TRUST, Compas and IN-TIME clinical studies, Biotronik’s home monitoring device has shown that it facilitates the daily transmission of remotely monitored data consisting of comprehensive information for the physicians, in a reliable and safe way which subsequently reduces instances of hospitalisation, stroke and mortality.
TRUST Trial lead investigator Dr Niraj Varma said: "The clinical and economic benefits of remote monitoring have been well established over a decade of clinical studies.
"But these benefits are only realised if patients consistently use the technology.
"When we make the remote monitoring process easy for patients, we increase the likelihood of patient adherence, which has been demonstrated to improve health outcomes."
Patient compliance and a consistent transmission of data necessary for physicians to prevent potential cardiac events is facilitated by the portability of the CardioMessenger Smart device.
Physicians can access to the fully automated provision of daily reports of cardiac activity through worldwide cellular networks to intervention from the patient.
Image:Biotronik’s CardioMessenger Smart device. Photo: courtesy of Biotronik.